AAAAAA

   
Results: 1-17 |
Results: 17

Authors: Couser, WG Shankland, SJ
Citation: Wg. Couser et Sj. Shankland, Recurrence of idiopathic nephrotic syndrome after renal transplantation - Guest commentary, J AM S NEPH, 12(9), 2001, pp. 1997-1999

Authors: Hiromura, K Haseley, LA Zhang, PM Monkawa, T Durvasula, R Petermann, AT Alpers, CE Mundel, P Shankland, SJ
Citation: K. Hiromura et al., Podocyte expression of the CDK-inhibitor p57 during development and disease, KIDNEY INT, 60(6), 2001, pp. 2235-2246

Authors: Couser, WG Pippin, JW Shankland, SJ
Citation: Wg. Couser et al., Complement (C5b-9) induces DNA synthesis in rat mesangial cells in vitro, KIDNEY INT, 59(3), 2001, pp. 905-912

Authors: Wolf, G Schroeder, R Zahner, G Stahl, RAK Shankland, SJ
Citation: G. Wolf et al., High glucose-induced hypertrophy of mesangial cells requires p27(Kip1), aninhibitor of cyclin-dependent kinases, AM J PATH, 158(3), 2001, pp. 1091-1100

Authors: Hughes, J Nangaku, M Alpers, CE Shankland, SJ Couser, WG Johnson, RJ
Citation: J. Hughes et al., C5b-9 membrane attack complex mediates endothelial cell apoptosis in experimental glomerulonephritis, AM J P-REN, 278(5), 2000, pp. F747-F757

Authors: Shankland, SJ Wolf, G
Citation: Sj. Shankland et G. Wolf, Cell cycle regulatory proteins in renal disease: role in hypertrophy, proliferation, and apoptosis, AM J P-REN, 278(4), 2000, pp. F515-F529

Authors: Kim, YG Suga, S Kang, DH Jefferson, JA Mazzali, M Gordon, KL Matsui, K Breiteneder-Geleff, S Shankland, SJ Hughes, J Kerjaschki, D Schreiner, GF Johnson, RJ
Citation: Yg. Kim et al., Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy, KIDNEY INT, 58(6), 2000, pp. 2390-2399

Authors: Shankland, SJ Eitner, F Hudkins, KL Goodpaster, T D'Agati, V Alpers, CE
Citation: Sj. Shankland et al., Differential expression of cyclin-dependent kinase inhibitors in human glomerular disease: Role in podocyte proliferation and maturation, KIDNEY INT, 58(2), 2000, pp. 674-683

Authors: Shankland, SJ
Citation: Sj. Shankland, New insights into the pathogenesis of membranous nephropathy, KIDNEY INT, 57(3), 2000, pp. 1204-1205

Authors: Shankland, SJ Al'Douahji, M
Citation: Sj. Shankland et M. Al'Douahji, Cell cycle regulatory proteins in glomerular disease, EXP NEPHROL, 7(3), 1999, pp. 207-211

Authors: Mundel, P Shankland, SJ
Citation: P. Mundel et Sj. Shankland, Glomerular podocytes and adhesive interaction with glomerular basement membrane, EXP NEPHROL, 7(2), 1999, pp. 160-166

Authors: Al-Douahji, M Brugarolas, J Brown, PAJ Stehman-Breen, CO Alpers, CE Shankland, SJ
Citation: M. Al-douahji et al., The cyclin kinase inhibitor p21(WAF1/CIP1) is required for glomerular hypertrophy in experimental diabetic nephropathy, KIDNEY INT, 56(5), 1999, pp. 1691-1699

Authors: Shankland, SJ
Citation: Sj. Shankland, Cell cycle regulatory proteins in glomerular disease, KIDNEY INT, 56(4), 1999, pp. 1208-1215

Authors: Shankland, SJ Pippin, JW Couser, WG
Citation: Sj. Shankland et al., Complement (C5b-9) induces glomerular epithelial cell DNA synthesis but not proliferation in vitro, KIDNEY INT, 56(2), 1999, pp. 538-548

Authors: Ophascharoensuk, V Giachelli, CM Gordon, K Hughes, J Pichler, R Brown, P Liaw, L Schmidt, R Shankland, SJ Alpers, CE Couser, WG Johnson, RJ
Citation: V. Ophascharoensuk et al., Obstructive uropathy in the mouse: Role of osteopontin in interstitial fibrosis and apoptosis, KIDNEY INT, 56(2), 1999, pp. 571-580

Authors: Kim, YG Alpers, CE Brugarolas, J Johnson, RJ Couser, WG Shankland, SJ
Citation: Yg. Kim et al., The cyclin kinase inhibitor p21(CIP1/WAF1) limits glomerular epithelial cell proliferation in experimental glomerulonephritis, KIDNEY INT, 55(6), 1999, pp. 2349-2361

Authors: Hiromura, K Pippin, JW Fero, ML Roberts, JM Shankland, SJ
Citation: K. Hiromura et al., Modulation of apoptosis by the cyclin-dependent kinase inhibitor p27(Kip1), J CLIN INV, 103(5), 1999, pp. 597-604
Risultati: 1-17 |